BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27859949)

  • 1. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression.
    Hattori T; Sentani K; Naohide O; Sakamoto N; Yasui W
    Cancer Sci; 2017 Jan; 108(1):143-150. PubMed ID: 27859949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress.
    Katsuya N; Sentani K; Sekino Y; Yamamoto Y; Kobayashi G; Babasaki T; Oue N; Amatya VJ; Takeshima Y; Yasui W
    Pathol Int; 2020 Dec; 70(12):943-952. PubMed ID: 33002285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
    Shigematsu Y; Oue N; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Hayashi T; Teishima J; Matsubara A; Yasui W
    Pathobiology; 2019; 86(4):208-216. PubMed ID: 31163419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer.
    Oue N; Naito Y; Hayashi T; Takigahira M; Kawano-Nagatsuma A; Sentani K; Sakamoto N; Zarni Oo H; Uraoka N; Yanagihara K; Ochiai A; Sasaki H; Yasui W
    Oncogene; 2014 Jul; 33(30):3918-26. PubMed ID: 23995782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPC18 Expression Is an Independent Prognostic Indicator of Patients with Esophageal Squamous Cell Carcinoma.
    Yamamoto Y; Oue N; Asai R; Katsuya N; Uraoka N; Sakamoto N; Sentani K; Tanabe K; Ohdan H; Yasui W
    Pathobiology; 2020; 87(4):254-261. PubMed ID: 32564026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
    Zhong G; Li H; Shan T; Zhang N
    Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
    Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
    Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma.
    Yang L; Lin XL; Liang W; Fu SW; Lin WF; Tian XQ; Gao YJ; Chen HY; Dai J; Ge ZZ
    Oncotarget; 2017 Jul; 8(29):47943-47956. PubMed ID: 28624786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.
    Lin BR; Chang CC; Che TF; Chen ST; Chen RJ; Yang CY; Jeng YM; Liang JT; Lee PH; Chang KJ; Chau YP; Kuo ML
    Gastroenterology; 2005 Jan; 128(1):9-23. PubMed ID: 15633118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells.
    Huang WS; Huang CY; Hsieh MC; Kuo YH; Tung SY; Shen CH; Hsieh YY; Teng CC; Lee KC; Lee KF; Kuo HC
    Cell Physiol Biochem; 2018; 51(6):2616-2630. PubMed ID: 30562740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.